Clinical Trials Browser

Phase 1/2 × INDUSTRY × siltuximab × Clear all

NCT00265135 2014-07-03

A Study of CNTO 328 in Subjects With Metastatic Renal Cell Carcinoma

Phase 1/2 Completed

Carcinoma, Renal Cell

NCT00841191 2014-05-14

A Safety, Efficacy and Pharmacokinetic Study of Siltuximab (CNTO 328) in Participants With Solid Tumors

Phase 1/2 Completed

GastrointestinalGynecologicHead & NeckThoracic

Head and Neck Neoplasms, Lung Neoplasms, Neoplasms by Histologic Type, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms